Home
3D VIDEOS
Sign up for Skype Consult or Office Visit today!
Plastic surgery advertisement is mostly directed towards women because 87% of all surgical and noninvasive cosmetic procedures in the United States are women. However plastic surgery for men is on the rise, by the latest statistics on male plastic surgery, men pick surgery to hide their faults while women use it to enhance their assets. Statistically, men preferred surgical solutions rather than repeated nonsurgical treatments. Although more men are undergoing noninvasive procedures, the number of surgical procedures for men are growing at a faster pace. Male facelifts has increased by 14% from 2009 to 2010, the fastest growing procedure. Also male rhinoplasty is still the most popular procedure done most often. These trends highlight the primary differences between what women want and what men what from cosmetic surgery. The most popular surgery for women is breast augmentation which helps gain self-esteem. Men, on the other hand, tend to favor more acute procedures that remove their faults, thus attaining self-esteem through subtraction. Men want procedures that come with hidden incision points, minimal scarring, and results that elicit a response of: “Have you lost some weight?” rather than: “Did you get a nose job.” Men’s desire for acute procedures that it has led plastic surgeons to come up with variation on common procedures. For example, a male’s facelift is handed quite differently from a female’s, for more subtle and masculine results. Cosmetic surgery for men continues to grow and gain acceptance. As long as plastic surgery solutions remain safe, affordable, and effective, men will continue to undergo cosmetic procedures
Mark A Bishara, M.D., P.A. Medical Director
This Information is Brought to you courtesy of Dr. Mark Bishara and The Paragon Plastic Surgery and Med Spa in Mansfield and Southlake.
Please also visit our Facebook page at Paragon Plastic Surgery and Medspa

We serve clients from the Dallas Fort Worth Metroplex:
,    , , Tyler
 

HOME
Sign up for Skype Consult or Office Visit today!
3D VIDEOS



interested-click-here




Medicis Pharmaceutical Corp is proud to  announce that the FDA has approved the use of the Restylane hyaluronic acid dermal filler to incorporate lip augmentation. Restylane was formerly approved to treat moderate to severe facial wrinkles and folds, such as the lines from the nose to the nasolabial folds. The new label will now include an indication for submucosal implantation for lip augmentation in patients over the age of 21.
Chairman and CEO of Medicis Jonah Shacknai, is pleased with FDA’s decision to expand the Restylane label to include lip augmentation. Restylane is now the first and only hyaluronic acid dermal filler approved in the United States for lip augmentation. 180 patients were evaluated during the study for six months. Safety was measured by adverse events reported throughout the study and patient diaries kept for two weeks after lip augmentation treatment.
Furthermore, Medicis designed nine lip safety assessments which were preformed at various intervals throughout the six month case study, including 72 hours after each treatment and again at two weeks after each treatment.
Mark A Bishara, M.D., P.A. Medical Director
This Information is Brought to you courtesy of Dr. Mark Bishara and The Paragon Plastic Surgery and Med Spa in Mansfield and Southlake.
Please also visit our Facebook page at Paragon Plastic Surgery and Medspa

We serve clients from the Dallas Fort Worth Metroplex:
 
,  

HOME
3D VIDEOS
Sign up for Skype Consult or Office Visit today!
Botox showed a statistically significant benefit for Botox over placebo. Without a headache indication the company can not promote data as U.S. Department of Justice is already investigating the off-label promotion of Botox for migraine. Allergan is said to be fully cooperating. Still, favorable data in studies will make physicians more likely to try it on patients suffering from migraines.
Botox costs $525 a vial, and 1.5 vials were used to treat headaches in the studies. Dr. David Simpson, a neurology professor at Mount Sinai School of Medicine, says there is a lot of off-label use in headaches now. He noted that in May of 2008, The American Academy of Neurology concluded that botulinum toxin type A was not an effective treatment for chronic headaches.
Biegelsen says current off-label use of Botox for migraine accounts for about $50 million, or 5% of total Botox sales and if Allergen gets the migraine indication, he believes sales could increase to about $400 million by 2012.
Mark A Bishara, M.D., P.A. Medical Director
This Information is Brought to you courtesy of Dr. Mark Bishara and The Paragon Plastic Surgery and Med Spa in Mansfield and Southlake.
Please also visit our Facebook page at Paragon Plastic Surgery and Medspa

  ,